Genetic Analysis of Biopsy-Related Droplets for Embryo Selection in PGT-A

A study of 318 biopsy-related droplets collected from 105 patients undergoing preimplantation genetic testing for aneuploidy (PGT-A). The dataset, authored by Zhiqing Huang and last updated in May 2026, contains results from genomic DNA amplification and next-generation sequencing to detect copy number variations and assess clinical pregnancy outcomes.

Use Cases

• Correlating nucleic acid content in droplets with blastocyst developmental day and ploidy.
• Evaluating consistency between droplet-based CNV detection and traditional PGT-A results.
• Assessing clinical pregnancy rates based on droplet-identified euploidy status.
• Investigating the utility of droplet analysis as a secondary method after initial PGT-A failure.

Strengths

• Contains data from 318 biopsy-related droplets, providing a substantial sample for analysis.
• Reports a specific clinical pregnancy rate comparison (84.62% vs 58.00%) based on droplet results.
• Includes a consistency rate (80.22%) between droplet CNV detection and primary PGT-A results.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The primary file format is DOCX, which may require extraction or conversion for structured analysis.

Provenance

Source

figshare

Collection Method

Biopsy-related droplets were collected during PGT-A procedures, followed by genomic DNA amplification and next-generation sequencing.

Time Range

The study period is not specified in the provided metadata.

Freshness

Last updated 2026-05-04 04:17:27; freshness should be verified.

Geography

The geographic coverage of the patient cohort is not specified.